Pacific Bio (PACB) Tops Q3 EPS by 1c

Pacific Bio (NASDAQ: PACB) reported Q3 EPS of ($0.19), $0.01 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $25.1 million versus the consensus estimate of $24.68 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Carnival shares drop despite earnings beat on weak guidance
• Bristow Group to acquire Berry Aviation for $105 million